Profound Medical (PROF) Net Income towards Common Stockholders (2024 - 2026)

Profound Medical has reported Net Income towards Common Stockholders for 3 years, with the latest figure at -$9.5 million in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 39.22% year-over-year to -$9.5 million in Q2 2026; TTM through Jun 2026 was $66.5 million, a 82.95% increase from a year earlier, with the FY2025 full-year figure at $42.6 million, up 53.04% from the prior year.
• Net Income towards Common Stockholders was -$9.5 million for Q2 2026 at Profound Medical, down from $7.1 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $77.0 million in Q4 2025, with the low at -$15.7 million in Q2 2025.
• Average Net Income towards Common Stockholders over 3 years is $8.9 million, with a median of -$6.8 million recorded in 2024.
• The largest YoY upside for Net Income towards Common Stockholders was 262.85% in 2025 against a maximum downside of 126.84% in 2025.
• Over 3 years, Net Income towards Common Stockholders stood at $50.7 million in 2024, then surged by 51.85% to $77.0 million in 2025, then tumbled by 112.4% to -$9.5 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$9.5 million (Q2 2026), $7.1 million (Q1 2026), and $77.0 million (Q4 2025), per Business Quant data.